Biocon

Biocon Secures ₹4,150 Crore Through QIP Backed By Strong Institutional Demand

Biocon Secures ₹4,150 Crore Through QIP Backed By Strong Institutional Demand

18 Jan 2026

1 min read

Biocon, Ajanta Pharma Enter Out-Licensing Pact To Market Semaglutide In 26 Countries

Biocon, Ajanta Pharma Enter Out-Licensing Pact To Market Semaglutide In 26 Countries

24 Dec 2025

1 min read

Biocon Integrates Biologics Arm In $5.5 B Deal To Create A Unified Global Biopharma Leader

Biocon Integrates Biologics Arm In $5.5 B Deal To Create A Unified Global Biopharma Leader

06 Dec 2025

2 min read

Read More

Voice Of HealthCare

vohnetwork.com